ASX-listed ResMed jumps on better-than-expected Q3 results
** ASX-listed shares of ResMed RMD.AX jump 9.2% to A$36.31; set for steepest one-day pct gain since April 26, 2024 ** Stock hits highest since March 11; top gainer on benchmark index .AXJO ** Healthcare tech co posts Q3 adjusted earnings per share of $2.37, marginally above analysts' estimate of $2.36 ** About 2.2 million shares traded, 1.3x the 30-day avg ** RMD loses 2.8% YTD (Reporting by Jasmeen Ara Shaikh in Bengaluru) ((JasmeenAraIslam.Shaikh@thomsonreuters.com;))
Recent news on ResMed
See all newsCiti lifts ResMed's ASX-listed stock's target price after FX, valuation updates
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
Brief: Resmed - Enters Accelerated Share Repurchase Agreement To Repurchase $450 Million Of Common Stock - SEC Filing
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT